American Academy of Neurology 2022 Annual Meeting Poster: Clinical evidence that treatment with pepinemab, a novel regulator of neuroinflammation, may provide cognitive benefit to patients with Huntington’s and potentially other neurodegenerative diseases
AACR Annual Meeting 2022 poster: Phase 1/2 study of pepinemab with pembrolizumab for first-line treatment of R/M Head and Neck Cancer
AACR Annual Meeting 2022 poster: Phase 1/2 study of pepinemab with pembrolizumab for first-line treatment of R/M Head and Neck Cancer
PEGS Boston 2022. Native complex membrane antigen expression on poxvirus for antibody discovery
PEGS Boston 2022. Native complex membrane antigen expression on poxvirus for antibody discovery
Synthesis of key results and conclusions of the SIGNAL phase 2 study of pepinemab as a treatment for early HD